Research and Markets: Concise Analysis of the International Peptide Therapeutics Market - Forecasts to 2018

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/cwlcm9/peptide) has announced the addition of the "Concise Analysis of the International Peptide Therapeutics Market - Forecasts to 2018" report to their offering.

To exploit the emerging international peptide therapeutics market, large pharmaceutical and biotechnological firms are actively investing in development of newer peptides for various applications and are also opting for newer technologies for syntheses of these peptides. Cancer is the leading cause of death globally; according to the WHO (World Health Organization), around 12.7 million new cancer cases occurred in the year 2008. About 7 million people die from cancer every year and it is estimated that there will be more than 16 million new cancer cases every year by 2020. With rise in cancer patients and metabolic diseases like diabetes, there has been a push in growth for peptide molecules since chemotherapy, which is the major mode of treatment for cancer, is facing major challenges due to its inability to deliver the correct amount of drug directly.

In addition, it affects the normal cells in the body. Peptide application in various other treatments has opened a promising avenue for future growth of this market. New routes of peptide administration are being investigated; however the parenteral route continues to dominate this market and accounted for a share of almost 86% of the entire market. Similarly, the technology market is ruled by LPPS (long phase peptide syntheses) and is anticipated to decline owing to huge demand for solid phase peptide syntheses and hybrid syntheses.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Global Peptide Therapeutics Market Dynamics

4 Global Peptide Therapeutics Market Analysis, By Applications

5 Global Peptide Therapeutics Market, by Route of Administration

6 Peptide Therapeutics Market - Generic & Innovative Segments

7 API Peptide Therapeutics Market, In-house Vs CMO

8 Peptide Therapeutics Market, By Technology

9 Peptide Therapeutics Market, By Geography

10 Market Share Analysis

11 Recommendations

12 Company Profiles

Companies Mentioned:

  • Amgen
  • Amylin Pharmaceuticals
  • Bristol-Myers Squibb
  • AstraZeneca
  • Bachem Holding
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Ipsen
  • Lonza
  • Merck & Co.
  • Novartis
  • Novo-Nordisk
  • Peptisyntha
  • Pfizer
  • PolyPeptide
  • Roche
  • Sanofi
  • Takeda Pharmaceutical Company
  • Teva Pharmaceuticals

For more information visit http://www.researchandmarkets.com/research/cwlcm9/peptide

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals